Comparing cancer treatment in the United States and Europe reveals striking differences in philosophy. The US system, often characterized as market-driven , tends to prioritize cutting-edge innovations , frequently resulting in higher costs and inconsistent access to care. Conversely, many European countries operate under publicly funded healthcare